These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34877519)

  • 1. Photoreactive-proton-generating hyaluronidase/albumin nanoparticles-loaded PEG-hydrogel enhances antitumor efficacy and disruption of the hyaluronic acid extracellular matrix in AsPC-1 tumors.
    Lee WT; Lee J; Kim H; Nguyen NT; Lee ES; Oh KT; Choi HG; Youn YS
    Mater Today Bio; 2021 Sep; 12():100164. PubMed ID: 34877519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermal paclitaxel-bound albumin nanoparticles co-loaded with indocyanine green and hyaluronidase for treating pancreatic cancers.
    Kim SS; Kim HK; Kim H; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
    Arch Pharm Res; 2021 Feb; 44(2):182-193. PubMed ID: 32803685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism Investigation of Hyaluronidase-Combined Multistage Nanoparticles for Solid Tumor Penetration and Antitumor Effect.
    Chen E; Han S; Song B; Xu L; Yuan H; Liang M; Sun Y
    Int J Nanomedicine; 2020; 15():6311-6324. PubMed ID: 32922003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery.
    Shi K; Wang Y; Zhou X; Gui H; Xu N; Wu S; He C; Zhao Z
    Acta Biomater; 2020 Sep; 114():369-383. PubMed ID: 32688090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Sequential Target-Responsive Nanocarrier with Enhanced Tumor Penetration and Neighboring Effect In Vivo.
    Cui T; Yan Z; Qin H; Sun Y; Ren J; Qu X
    Small; 2019 Oct; 15(42):e1903323. PubMed ID: 31468717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix-degrading soft-nanoplatform with enhanced tissue penetration for amplifying photodynamic therapeutic efficacy of breast cancer.
    Lu W; Wang N; Liu X; Chen D; Li Q; Rui J; Ning W; Shi X; Li C; Zhao Y; He A; Teng Z
    J Mater Chem B; 2024 Jul; ():. PubMed ID: 39016097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration.
    Dai J; Han S; Ju F; Han M; Xu L; Zhang R; Sun Y
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):860-873. PubMed ID: 29771149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Photopolymerized Semi-Interpenetrating Polymer Networks-Based Hydrogel Incorporated with Nanoparticle for Local Chemotherapy of Tumors.
    Wang Y; Li Q; Zhou JE; Tan J; Li M; Xu N; Qu F; Chen J; Li J; Wang J; Liang Z; Yu L; Wang Y; Yan Z
    Pharm Res; 2021 Apr; 38(4):669-680. PubMed ID: 33796952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size-shrinkable and protein kinase Cα-recognizable nanoparticles for deep tumor penetration and cellular internalization.
    Ma JB; Shen JM; Yue T; Wu ZY; Zhang XL
    Eur J Pharm Sci; 2021 Apr; 159():105693. PubMed ID: 33383133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrochemiluminescence Biosensor for Hyaluronidase Based on the Ru(bpy)
    Li Z; Zhang J; Chen H; Huang X; Huang D; Luo F; Wang J; Guo L; Qiu B; Lin Z
    ACS Appl Bio Mater; 2020 Feb; 3(2):1158-1164. PubMed ID: 35019317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient PD-L1 gene silence promoted by hyaluronidase for cancer immunotherapy.
    Guan X; Lin L; Chen J; Hu Y; Sun P; Tian H; Maruyama A; Chen X
    J Control Release; 2019 Jan; 293():104-112. PubMed ID: 30476528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Nanodrugs to Destroy the Tumor Extracellular Matrix Barrier for Improving Drug Delivery and Cancer Therapeutic Efficacy.
    Chen M; Chen B; Ge X; Ma Q; Gao S
    Mol Pharm; 2023 May; 20(5):2389-2401. PubMed ID: 37042638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
    Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
    Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas.
    Cheng WT; Ho HO; Lin SY; Liu DZ; Chen LC; Sheu MT
    Int J Nanomedicine; 2021; 16():6825-6841. PubMed ID: 34675510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma.
    Ruan C; Liu L; Lu Y; Zhang Y; He X; Chen X; Zhang Y; Chen Q; Guo Q; Sun T; Jiang C
    Acta Pharm Sin B; 2018 Jan; 8(1):85-96. PubMed ID: 29872625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy.
    Ding D; Tang X; Cao X; Wu J; Yuan A; Qiao Q; Pan J; Hu Y
    AAPS PharmSciTech; 2014 Feb; 15(1):213-22. PubMed ID: 24287627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Antitumor Therapy Using In Situ Injectable Hydrogels Formulated with Albumin Nanoparticles Containing Indocyanine Green, Chlorin e6, and Perfluorocarbon in Hypoxic Tumors.
    Lee WT; Yoon J; Kim SS; Kim H; Nguyen NT; Le XT; Lee ES; Oh KT; Choi HG; Youn YS
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
    Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q
    Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
    Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
    J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
    Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
    Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.